Vascular Inflammation Clinical Trials
2 recruiting trials for Vascular Inflammation. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Vascular Inflammation clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Johann Wolfgang Goethe University Hospital (1), Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Cardiac Imaging (diagnostic_test, 1 trial), followed by High-resolution retinal imaging through adaptive optics, High-resolution retinal imaging through holographic systems.
Track Vascular Inflammation trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Magnetic properties of myocardial tissue change in the presence of disease. This is detectable in the change of rate of magnetic relaxation, and measurable by T1 and T2 mapping...
High Resolution, High-speed Multimodal Ophthalmic Imaging
Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Vascular Inflammation, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Vascular Inflammation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Vascular Inflammation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.